Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3298

Actual shortage: 230 (7%)
Anticipated shortage: 3 (0%)
Avoided shortage: 9 (0%)
Resolved: 3056 (93%)

Discontinuation Reports

359

To be discontinued: 24 (7%)
Discontinued: 335 (93%)
Reversed: 0 (0%)

Late reports

143 (4%)

Overdue reports

28 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Actual shortage 2025-02-06 2025-02-06 249766
APO-SUCRALFATE - TAB 1G 1G TABLET Actual shortage 2025-02-06 2025-02-06 249763
APO-CLARITHROMYCIN 500MG TABLET Actual shortage 2025-02-06 2025-02-06 249760
APO-DORZO-TIMOP 5MG 20MG SOLUTION SOLUTION Actual shortage 2025-02-06 2025-02-06 249755
APO-LANSOPRAZOLE 30MG CAPSULE (DELAYED RELEASE) Actual shortage 2025-02-06 2025-02-06 249752
APO-CLOPIDOGREL 75MG TABLET Actual shortage 2025-02-06 2025-02-06 249749
APO-MELOXICAM 1.5G SUSPENSION Actual shortage 2025-02-06 2025-02-06 249746
APO-HYDROXYUREA 500MG CAPSULE CAPSULE Actual shortage 2025-01-30 2025-01-30 249096
APO-AMPHETAMINE XR 25MG CAPSULE (EXTENDED RELEASE) Actual shortage 2025-01-30 2025-01-30 249092
APO-RISPERIDONE 0.50MG TABLET Actual shortage 2025-01-30 2025-01-30 249089
APO-METRONIDAZOLE TABLETS 250MG TABLET Actual shortage 2025-01-30 2025-01-30 249080
APO-CANDESARTAN TABLETS 8MG TABLET Actual shortage 2025-01-30 2025-01-30 249077
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Actual shortage 2025-01-30 2025-01-30 249074
APO-APREMILAST 30MG TABLET Resolved 2025-01-24 2025-01-31 248558
APO-RIVASTIGMINE 4.5MG CAPSULE Actual shortage 2025-01-23 2025-02-06 248492
APO-NAPROXEN 500MG TABLET Actual shortage 2025-01-23 2025-01-23 248489
APO-BRIVARACETAM 75MG TABLET Actual shortage 2025-01-23 2025-01-23 248486
APO-METRONIDAZOLE 500MG CAPSULE Actual shortage 2025-01-23 2025-01-23 248483
APO-OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Actual shortage 2025-01-16 2025-01-16 247901
APO-ARIPIPRAZOLE 15MG TABLET Resolved 2025-01-16 2025-01-31 247894

Showing 1 to 20 of 3298

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-NORTRIPTYLINE 25MG CAPSULE Discontinued 2017-03-13 2017-03-13 1155
APO-NORTRIPTYLINE 10MG CAPSULE Discontinued 2017-03-13 2017-03-13 1145
APO-NIZATIDINE 300MG CAPSULE Discontinued 2017-03-13 2017-03-13 1135
APO-NIZATIDINE 150MG CAPSULE Discontinued 2017-03-13 2017-03-13 1127
APO-NITRAZEPAM 10MG TABLET Discontinued 2017-03-13 2018-12-07 1117
APO-NITRAZEPAM 5MG TABLET Discontinued 2017-03-13 2018-12-07 1110
APO-METOCLOP TAB 5MG 5mg tablet Discontinued 2017-03-13 2017-03-13 1105
APO-METOCLOP TAB 10MG 10MG TABLET Discontinued 2017-03-13 2017-03-13 1101
APO-LISINOPRIL/HCTZ 25MG 20MG TABLET Discontinued 2017-03-13 2017-03-13 1096
APO-LISINOPRIL/HCTZ 12.5MG 10MG TABLET Discontinued 2017-03-13 2017-03-13 1093
APO-LISINOPRIL/HCTZ 12.5MG 20MG TABLET Discontinued 2017-03-13 2017-03-13 1090
APO-HALOPERIDOL TAB 5MG 5MG TABLET Discontinued 2017-03-13 2017-03-13 1087
APO-HALOPERIDOL TAB 2MG 2MG TABLET Discontinued 2017-03-13 2017-03-13 1084
APO-DILTIAZ TZ 360MG CAPSULE (EXTENDED RELEASE) Discontinued 2017-03-13 2017-03-13 1078
APO-DILTIAZ TZ 300MG CAPSULE (EXTENDED RELEASE) Discontinued 2017-03-13 2017-03-13 1075
APO-DILTIAZ TZ 240MG CAPSULE (EXTENDED RELEASE) Discontinued 2017-03-13 2017-03-13 1072
APO-DILTIAZ TZ 180MG CAPSULE (EXTENDED RELEASE) Discontinued 2017-03-13 2017-03-13 1069
APO-DILTIAZ TZ 120MG CAPSULE (EXTENDED RELEASE) Discontinued 2017-03-13 2017-03-13 1064
APO PREDNISONE TAB 1MG USP 1MG TABLET Discontinued 2017-03-13 2017-03-13 1056

Showing 341 to 359 of 359